Decipher Genomics Resource News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Decipher genomics resource. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Decipher Genomics Resource Today - Breaking & Trending Today

Integrating Genomic and Clinicopathologic Risk Groups May Improve Prognostication in Prostate Cancer

Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer. Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer. ....

United States , Veracyte Inc , Society Of Urologic Oncology Annual Meeting , Urologic Oncology Annual Meeting , Decipher Genomics Resource , Intelligent Discovery ,

SUO 2023: Advances in Prostate Cancer

Studies presented at SUO 2023 have shed new light on risk stratification and novel treatments in prostate cancer. Studies presented at SUO 2023 have shed new light on risk stratification and novel treatments in prostate cancer. ....

Mayo Clinic In Rochester , United States , Blue Earth , New York , Ann Arbor , Christian Pavlovich , Oliver Sartor , Wesley Yip , Amgen Teneobio , Lantheus Progenics , Myovant Sumitomo Pharma , Veracyte Inc , Johns Hopkins University In Baltimore , Telix Pharmaceuticals , University Of Michigan , National Comprehensive Cancer Network , Clarity Pharmaceuticals , Society Of Urologic Oncology , Urologic Oncology , Annual Meeting , Johns Hopkins University , Results With , Mayo Clinic , Weill Cornell Medicine , Decipher Genomics Resource , Intelligent Discovery ,

Integrating Genomic and Clinicopathologic Risk Groups May Improve Prognostication in Prostate Cancer

Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer. Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer. ....

United States , Society Of Urologic Oncology Annual Meeting , Urologic Oncology Annual Meeting , Decipher Genomics Resource , Intelligent Discovery ,

Study Data Shows Potential of Gene Signatures to Predict Treatment Response in Patients With Recurrent Prostate Cancer

The research was aided by the Decipher Genomics Resource for Intelligent Discovery, which helped derive the gene signatures used during the analysis. ....

Andrew Armstrong , Elai Davicioni , Duke Cancer Institute Center , Decipher Genomics Resource , Intelligent Discovery , Urologic Cancers ,

Veracyte Announces that Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate Cancer

New data are from a retrospective analysis of the Phase 2 STREAM trial

. ....

United States , South San Francisco , Andrew Armstrong , Elai Davicioni , Research Use , Duke University , Veracyte Inc , Duke Cancer Institute Center , Decipher Genomics Resource , Intelligent Discovery , Urologic Cancers , Research Use Only , Annual Report , Quarterly Report , For Research Use Only ,